Metraipolis › archive › dc_e88ef516b641

Montelukast: risk of mental disorders vs. efficacy-a meta-analysis — Europe PMC PMID:41208871

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41208871
DOI
10.3389/fphar.2025.1659852
License (as archived)
solo-consultazione
Archived
2026-11-09T02:13:08.965Z
SHA-256 of the archived text
ca2e0989d1955c22fdf40f321bade8dc338162b771f81779f78d20d885e38372
Stable URL of this page
https://metraipolis.com/documento/dc_e88ef516b641

How to cite

Montelukast: risk of mental disorders vs. efficacy-a meta-analysis — Europe PMC PMID:41208871 — Europe PMC (en), https://europepmc.org/article/MED/41208871 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e88ef516b641 (Metraipolis archive dc_e88ef516b641, sha256 ca2e0989d1955c22fdf40f321bade8dc338162b771f81779f78d20d885e38372)
BibTeX
@misc{dce88ef516b641,
  title = {Montelukast: risk of mental disorders vs. efficacy-a meta-analysis — Europe PMC PMID:41208871},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208871},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e88ef516b641; sha256 ca2e0989d1955c22fdf40f321bade8dc338162b771f81779f78d20d885e38372},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208871. Agents can read the archived copy with the MCP tool read_document.